CARDIFF ONCOLOGY INC (CRDF) Institutional Shareholders

CARDIFF ONCOLOGY INC (CRDF) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $22.54M in CRDF holdings during the latest filing period.

Laurion Capital Management Lp is currently the largest disclosed institutional shareholder of CRDF tracked by InsiderSet, reporting ownership valued at approximately $4.03M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $4.03M, representing an estimated loss of -0.00% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 75% of the total disclosed CRDF value among the investors covered in this analysis. Major shareholders include Laurion Capital Management Lp, Vanguard Capital Management Llc, Pfizer Inc, and several other long-term asset managers with concentrated positions in CARDIFF ONCOLOGY INC (CRDF).

This page ranks the largest institutional CRDF shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

100

Total Reported Value

$22.54M

Largest Holder

Laurion Capital Management Lp

Largest Position

$4.03M

Insider Transactions (90d)

2

Latest Filing Quarter

Q2 2026

New Institutional Positions

146

Funds Exiting Positions

0

NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Laurion Capital Management Lp0.29%3,098,299$4,027,789$4,027,789-$0-0.00%
Vanguard Capital Management Llc0.00%2,895,592$3,764,270$3,764,270-$0-0.00%
Pfizer Inc1.77%2,411,575$3,014,469$3,135,048+$120,579+4.00%
Blackrock, Inc.0.00%972,873$1,264,735$1,264,735-$0-0.00%
Blair William & Co/Il0.00%912,513$1,186,267$1,186,267-$0-0.00%
Geode Capital Management, Llc0.00%820,062$1,066,639$1,066,081-$558-0.05%
Ubs Group Ag0.00%638,699$830,309$830,309-$0-0.00%
Jane Street Group, Llc0.00%607,900$790,270$790,270$00.00%
Vanguard Fiduciary Trust Co0.00%410,602$533,783$533,783-$0-0.00%
Aqr Capital Management Llc0.00%346,353$450,260$450,259-$1-0.00%
State Street Corp0.00%331,395$430,814$430,814-$1-0.00%
Hrt Financial Lp0.00%272,786$354,000$354,622+$622+0.18%
Flputnam Investment Management Co0.00%247,474$321,716$321,716+$0+0.00%
Morgan Stanley0.00%246,095$319,924$319,924-$1-0.00%
Bnp Paribas Financial Markets0.00%228,461$296,999$296,999+$0+0.00%
X-Square Capital, Llc0.07%205,700$267,000$267,410+$410+0.15%
Gsa Capital Partners Llp0.01%173,274$225,000$225,256+$256+0.11%
Marshall Wace, Llp0.00%162,214$210,879$210,878-$1-0.00%
Bank Of New York Mellon Corp0.00%161,689$210,196$210,196-$0-0.00%
Northern Trust Corp0.00%152,875$198,738$198,738-$1-0.00%
Avestar Capital, Llc0.01%136,145$176,989$176,989-$1-0.00%
Millennium Management Llc0.00%134,517$174,872$174,872+$0+0.00%
Qube Research & Technologies Ltd0.00%125,550$163,215$163,215$00.00%
Goldman Sachs Group Inc0.00%120,827$157,076$157,075-$1-0.00%
Susquehanna International Group, Llp0.00%116,138$150,979$150,979+$0+0.00%
Alphacore Capital Llc0.00%108,493$141,041$141,041-$0-0.00%
Xtx Topco Ltd0.00%97,400$126,620$126,620$00.00%
Squarepoint Ops Llc0.00%96,090$124,917$124,917$00.00%
Vanguard Portfolio Management Llc0.00%72,057$93,674$93,674+$0+0.00%
Virtu Financial Llc0.00%71,328$93,000$92,726-$274-0.29%
Assenagon Asset Management S.A.0.00%67,231$87,400$87,400+$0+0.00%
Capstone Investment Advisors, Llc0.00%51,190$66,547$66,547$00.00%
Mariner, Llc0.00%49,356$64,163$64,163-$0-0.00%
Elkhorn Partners Limited Partnership0.05%48,000$62,400$62,400$00.00%
Two Sigma Investments, Lp0.00%47,666$61,966$61,966-$0-0.00%
Ieq Capital, Llc0.00%44,630$58,019$58,019$00.00%
Glenview Trust Co0.00%43,128$56,066$56,066+$0+0.00%
Dimensional Fund Advisors Lp0.00%36,650$47,645$47,645$00.00%
Rhumbline Advisers0.00%30,064$39,083$39,083+$0+0.00%
Point72 Asset Management, L.P.0.00%28,385$36,901$36,901-$1-0.00%
Hsbc Holdings Plc0.00%28,996$36,825$37,695+$870+2.36%
Quadrature Capital Ltd0.00%26,867$34,927$34,927+$0+0.00%
Vanguard Global Advisers, Llc0.00%25,271$32,852$32,852+$0+0.00%
Engineers Gate Manager Lp0.00%24,994$32,492$32,492+$0+0.00%
Tamar Securities, Llc0.00%23,795$30,934$30,934-$1-0.00%
Mai Capital Management0.00%23,373$30,385$30,385-$0-0.00%
Raymond James Financial Inc0.00%22,672$29,473$29,474+$1+0.00%
Post Resch Tallon Group Inc.0.02%22,515$29,270$29,270-$1-0.00%
Y-Intercept (Hong Kong) Ltd0.00%22,388$29,104$29,104+$0+0.00%
R Squared Ltd0.02%22,018$28,623$28,623+$0+0.00%
Showing 50 of 100

Frequently asked questions about CRDF

  • Who owns the most CRDF stock?

    The largest holders of CRDF are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for CARDIFF ONCOLOGY INC (CRDF).

  • Is CRDF widely held by superinvestors?

    Many widely followed stocks like CRDF appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly CRDF is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.